Introduction
Intravenous administration of glucagon to normal man is known to increase plasma concentrations of glucose, adenosine 3'5'-cyclic monophosphate (cyclic AMP) and insulin. Glucagon acts to stimulate adenylate cyclase in liver cells resulting in glycogenolysis and gluconeogenesis (Francavilla, Jones and Starzl, 1978) . Van Itallie and Bentley (1955) infused glucagon into normal subjects and cirrhotic patients in the presence and absence of subcutaneously administered adrenaline and suggested that glucagon-adrenaline induced hyperglycaemia may be of value as an index of liver function. Patients with acute viral hepatitis and healthy subjects also showed a marked difference in their plasma glucose response to intravenous glucagon (Felig et al., 1970 (67±03 v. 4 8±02 mmol/litre), 30 min (7 7 ± 0 3 v. 5 2 ± 0 2) and 45 min (7.9 ±04 v. 50±002). The two groups were best differentiated at 45 min where only patients with obstructive jaundice (78% of the obstructive group) had plasma glucose levels greater than 7 0 mmol/ litre. Mean plasma glucose concentrations in normal subjects were 6-3 ± 0 1, 6-2 ± 0-2 and 4-8 ± 0-2 mmol/ litre at 15, 30 and 45 min respectively. The glucose response to glucagon in 5 patients with pancreatic carcinoma did not differ significantly from the response in the 13 patients with gallstones. 
Discussion
Previous studies have raised the potential value of a glucagon test as a measure of liver function. These tests have involved either continuous infusions of glucagon (Felig et al., 1970; Francavilla et al., 1978) or repeated bolus doses (Van Itallie and Bentley, 1955) whereas the present test involves only a single bolus injection of glucagon.
Although the differentiation of jaundice into obstructive or hepatocellular on the basis of clinical examination and routine biochemical tests is straightforward in the majority of cases, in a small The above measurements show that the blood glucose at 45 min after glucagon injection was the best single discriminant in separating the two jaundiced groups. Only those patients with obstructive jaundice showed an appreciable rise in blood glucose, whereas those with hepatocellular jaundice tended to have a flat glucose response.
The low levels of fasting glucose found in a large proportion of the hepatocellular group have been observed previously in patients with viral hepatitis (Felig et al., 1970) . The underlying mechanisms involved in the differing response of jaundiced patients to glucagon are likely to be complex resulting from differences in hepatic glycogen content, insulin and glucose metabolism and other factors affecting carbohydrate metabolism. It is of some interest that patients with longstanding obstruction showed a marked rise in blood sugar after glucagon, whilst two patients who had very mild hepatitis clinically with little or no constitutional upset, nor any marked biochemical abnormality other than a raised bilirubin, had very flat glucose response curves to glucagon. These cases serve to emphasize the possible value of the above test which when used in conjunction with other biochemical investigations may increase the accuracy of diagnosis in jaundice.
